GS 930

Drug Profile

GS 930

Alternative Names: cHPMPC; cyclic cidofovir; cyclic HPMPC; cyclic-CDV

Latest Information Update: 15 Mar 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Gilead Sciences
  • Class Antivirals; Phosphonic acids; Small molecules
  • Mechanism of Action DNA-directed DNA polymerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Cytomegalovirus infections; Herpes simplex virus infections; HIV infections

Most Recent Events

  • 22 Nov 1999 Suspended-I for Cytomegalovirus infections in USA (PO)
  • 22 Nov 1999 Suspended-I for HIV infections treatment in USA (PO)
  • 22 Nov 1999 Suspended-Preclinical for Herpes simplex virus infections in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top